ZURICH Swiss drugmaker Roche lifted its 2019 outlook on Wednesday, as sales growth in China and the United States outpaced price declines it has suffered amid President Donald Trump's pressure on the industry to hold down charges.
ZURICH Three Germans on trial in Switzerland for helping expose a tax-stripping scheme that cost European governments billions of euros will likely avoid prison after a verdict on Thursday that fell well short of prosecutors' demands.
ZURICH Switzerland on Wednesday announced plans to abolish the nation's emergency stockpile of coffee, in place for decades, after declaring the beans not vital for human survival, though opposition to the proposal is brewing.
ZURICH Swiss eyecare company Alcon made its debut on the SIX Swiss Exchange on Tuesday with a market capitalization of more than $25 billion after a shareholder spin-off from drugmaker Novartis, the Alpine nation's biggest stock deal in a decade.
ZURICH Biogen Inc should slash the price of its spinal muscular atrophy (SMA) drug, and the $4 million to $5 million Novartis has said its experimental gene therapy for the disease is worth is excessive, an independent U.S. organization that reviews the value of medical treatments said on Wednesday.
ZURICH Biogen Inc should slash the price of its spinal muscular atrophy (SMA) drug, and the $4 million to $5 million Novartis has said its experimental gene therapy for the disease is worth is excessive, an independent U.S. organization that reviews the value of medical treatments said on Wednesday.
ZURICH, April 3 Biogen Inc should slash the price of its spinal muscular atrophy (SMA) drug, and the $4 million to $5 million Novartis has said its experimental gene therapy for the disease is worth is excessive, an independent U.S. organization that reviews the value of medical treatments said on Wednesday.
ZURICH Novartis's spinoff of its eyecare division Alcon, set for Tuesday April 9, marks the largest Swiss stock deal in a decade and forces a reshuffle of the benchmark Swiss Market Index (SMI) as private bank Julius Baer gets booted out.
Myanmar's top court on Tuesday rejected the appeal of two Reuters reporters sentenced to seven years in jail for breaking the Official Secrets Act, in a landmark case that has raised questions about the country's transition to democracy.